Korea/Asia, Events, IPOs, Douglas Research Advisory

Douglas Kim

Korea/Asia, Events, IPOs

Equity Capital Markets

<ul>
<li>Lunit is getting ready to complete its IPO in Korea in July. The IPO base deal size is from $42 million to $46 million.</li>
<li>Established in 2013, Lunit is one of the leading companies in Korea that specializes in AI-based cancer diagnosis and treatment solutions.</li>
<li>Lunit is a pioneer in the medical artificial intelligence industry. The company has developed and commercialized AI-assisted detection solutions that complement human visual limitations through deep learning technology. </li>
</ul>


Lunit is getting ready to complete its IPO in Korea in July. The IPO base deal size is from $42 million to $46 million.
Established in 2013, Lunit is one of the leading companies in Korea that specializes in AI-based cancer diagnosis and treatment solutions.
Lunit is a pioneer in the medical artificial intelligence industry. The company has developed and commercialized AI-assisted detection solutions that complement human visual limitations through deep learning technology. 


Lunit IPO Preview: A Pioneer in AI-Based Cancer Diagnosis and Treatment Solutions

South Korea

Lunit Inc. operates as a medical software company. The Company develops chest x-ray analysis artificial intelligence software, mammography analysis artificial intelligence software, immunooncology tissue phenomics artificial intelligence software, and expression analysis artificial intelligence software. Lunit markets its products worldwide.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Lunit (328130 KS)

Lunit IPO Preview: A Pioneer in AI-Based Cancer Diagnosis and Treatment Solutions

Lunit is getting ready to complete its IPO in Korea in July. Lunit is one of the leading companies in Korea that specializes in AI-based cancer...

Douglas Kim

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)